Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1991 Aug;59(8):2529–2534. doi: 10.1128/iai.59.8.2529-2534.1991

Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites.

Z M Khan 1, J P Vanderberg 1
PMCID: PMC258051  PMID: 1855974

Abstract

We found BALB/c mice to be on the order of 2,000 times more susceptible to Plasmodium yoelii than Plasmodium berghei sporozoites, as measured by the ability of these sporozoites to differentiate into microscopically detectable hepatic schizonts in the livers of immunologically naive mice. One of the factors that determine the relative insusceptibility of mice to P. berghei sporozoites is the innate cellular inflammatory response that the mice mount after injection with sporozoites. The cellular inflammatory response against P. berghei is initiated soon after sporozoite injection; by 24 h, substantial histopathological changes have developed within the liver. There is considerably less of a cellular inflammatory response against P. yoelii; significant histopathological changes within the liver are not observed until well after hepatic schizonts have begun to rupture at around 44 h postinjection of sporozoites. These differences in the cellular inflammatory response against two different, closely related species of sporozoites are of considerable interest. The data strongly suggest that the BALB/c-P. berghei sporozoite system is a relatively poor biological model for sporozoite immunization studies.

Full text

PDF
2529

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Landau I., Killick-Kendrick R. Rodent plasmodia of the République Centrafricaine: the sporogony and tissue stages of Plasmodium chabaudi and P. berghei yoelii. Trans R Soc Trop Med Hyg. 1966;60(5):633–649. doi: 10.1016/0035-9203(66)90010-1. [DOI] [PubMed] [Google Scholar]
  2. Most H., Nussenzweig R. S., Vanderberg J., Herman R., Yoeli M. Susceptibility of genetically standardized (JAX) mouse strains to sporozoite- and blood-induced Plasmodium berghei infections. Mil Med. 1966 Sep;131(9 Suppl):915–918. [PubMed] [Google Scholar]
  3. Nussenzweig V., Nussenzweig R. S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol. 1989;45:283–334. doi: 10.1016/s0065-2776(08)60695-1. [DOI] [PubMed] [Google Scholar]
  4. Vanderberg J. P., Chew S., Stewart M. J. Plasmodium sporozoite interactions with macrophages in vitro: a videomicroscopic analysis. J Protozool. 1990 Nov-Dec;37(6):528–536. doi: 10.1111/j.1550-7408.1990.tb01260.x. [DOI] [PubMed] [Google Scholar]
  5. Vanderberg J. P., Nussenzweig R. S., Most H. Further studies on the Plasmodium berghei-Anopheles stephensi--rodent system of mammalian malaria. J Parasitol. 1968 Oct;54(5):1009–1016. [PubMed] [Google Scholar]
  6. Vanderberg J. P. Plasmodium berghei: quantitation of sporozoites injected by mosquitoes feeding on a rodent host. Exp Parasitol. 1977 Jun;42(1):169–181. doi: 10.1016/0014-4894(77)90075-3. [DOI] [PubMed] [Google Scholar]
  7. Weiss W. R. Host-parasite interactions and immunity to irradiated sporozoites. Immunol Lett. 1990 Aug;25(1-3):39–42. doi: 10.1016/0165-2478(90)90088-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES